Charles Rhyee
Stock Analyst at TD Cowen
(0.77)
# 3,776
Out of 4,854 analysts
52
Total ratings
30.3%
Success rate
-14.83%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Downgrades: Hold | $254 → $157 | $139.11 | +12.86% | 4 | Apr 14, 2025 | |
| MEDP Medpace Holdings | Downgrades: Hold | $370 → $328 | $296.50 | +10.62% | 4 | Apr 14, 2025 | |
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $154.71 | -6.92% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $144.70 | +56.88% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $5.28 | +373.48% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $7.27 | +10.04% | 6 | Oct 31, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $285.36 | -32.72% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.08 | +292.16% | 7 | May 16, 2024 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $3.29 | +51.98% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $6.96 | +618.39% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $152.32 | +64.78% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $6.16 | +809.09% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.70 | +1,897.15% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $8.33 | +500.24% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $712.89 | -49.36% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $1.53 | +211,664.71% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $22.94 | +52.61% | 1 | Feb 13, 2018 |
ICON Public Limited Company
Apr 14, 2025
Downgrades: Hold
Price Target: $254 → $157
Current: $139.11
Upside: +12.86%
Medpace Holdings
Apr 14, 2025
Downgrades: Hold
Price Target: $370 → $328
Current: $296.50
Upside: +10.62%
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $154.71
Upside: -6.92%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $144.70
Upside: +56.88%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $5.28
Upside: +373.48%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $7.27
Upside: +10.04%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $285.36
Upside: -32.72%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.08
Upside: +292.16%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $3.29
Upside: +51.98%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $6.96
Upside: +618.39%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $152.32
Upside: +64.78%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $6.16
Upside: +809.09%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.70
Upside: +1,897.15%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $8.33
Upside: +500.24%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $712.89
Upside: -49.36%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $1.53
Upside: +211,664.71%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $22.94
Upside: +52.61%